Ibaraki Children's Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2012
NCT01501786
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Ibaraki Children's Hospital | Kazuhiko Okuyama, MD

Active Ingredients

Drugs in Other Trials (1)

ketamine (ketalar) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1